RO7790121, RO7790121 placebo/diluent
CS45943
Phase 2 small_molecule active
Quick answer
RO7790121, RO7790121 placebo/diluent for Atopic Dermatitis is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active